These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 12633914)
1. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results. Bochud Tornay C; Favrat B; Monnat M; Daeppen JB; Schnyder C; Bertschy G; Besson J Drug Alcohol Depend; 2003 Apr; 69(3):283-8. PubMed ID: 12633914 [TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts. Hensel M; Kox WJ Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849 [TBL] [Abstract][Full Text] [Related]
3. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared. McKeganey N; Russell C; Cockayne L J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715 [TBL] [Abstract][Full Text] [Related]
4. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Bell JR; Young MR; Masterman SC; Morris A; Mattick RP; Bammer G Med J Aust; 1999 Jul; 171(1):26-30. PubMed ID: 10451668 [TBL] [Abstract][Full Text] [Related]
5. Ultra rapid opiate detoxification as compared to 30-day inpatient detoxification program--a retrospective follow-up study. Lawental E J Subst Abuse; 2000; 11(2):173-81. PubMed ID: 10989777 [TBL] [Abstract][Full Text] [Related]
7. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users. Lubman D; Koutsogiannis Z; Kronborg I Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133 [TBL] [Abstract][Full Text] [Related]
8. Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. Cucchia AT; Monnat M; Spagnoli J; Ferrero F; Bertschy G Drug Alcohol Depend; 1998 Nov; 52(3):243-50. PubMed ID: 9839150 [TBL] [Abstract][Full Text] [Related]
9. Heroin anticraving medications: a systematic review. Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107 [TBL] [Abstract][Full Text] [Related]
11. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran. Naderi-Heiden A; Naderi A; Naderi MM; Rahmani-Didar F; Salimi AR; Gleiss A; Kasper S; Frey R Pharmacopsychiatry; 2010 Jun; 43(4):130-7. PubMed ID: 20101570 [TBL] [Abstract][Full Text] [Related]
12. Naltrexone and buprenorphine combination in the treatment of opioid dependence. Gerra G; Fantoma A; Zaimovic A J Psychopharmacol; 2006 Nov; 20(6):806-14. PubMed ID: 16401652 [TBL] [Abstract][Full Text] [Related]
13. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. Collins ED; Kleber HD; Whittington RA; Heitler NE JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380 [TBL] [Abstract][Full Text] [Related]
14. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)]. Duburcq A; Charpak Y; Blin P; Madec L Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303 [TBL] [Abstract][Full Text] [Related]